Steroid-refractory Diamond-Blackfan Anemia (DBA)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Steroid-refractory Diamond-Blackfan Anemia (DBA) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedPhase 1/2

NCT05828108

Study of the Selective GlyT1 Inhibitor Bitopertin for Steroid-Refractory Diamond-Blackfan Anemia

Background: Diamond-Blackfan anemia (DBA) is an inherited disease that affects the bone marrow. People with DBA have chronic anemia that can be severe. Many mu…

United States15 participantsStarted 2023-07-25

Treatment: Bitopertin